In fiscal 2023, which ended Dec 31, 2023, NP Life Sciences Health Industry Group Inc. used $73,607 of cash from operations, down 178.4% from the year before.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
|---|---|---|---|---|---|
| Operating | |||||
| Operating cash flow |
-0
-178.4%
|
0
+203.6%
|
-0
+27.1%
|
-0
-2814.3%
|
-0
|
| Investing | |||||
| Investing cash flow |
—
|
—
|
—
|
—
|
-0
|
| Financing | |||||
| Debt issued |
0
|
—
|
—
|
—
|
—
|
| Financing cash flow |
0
|
—
|
—
|
—
|
0
|
| Change in cash | |||||
| Net change in cash |
-0
-154.6%
|
0
+203.6%
|
-0
+27.1%
|
-0
-151.2%
|
0
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Services-Educational Services (SIC 8200)
- Listed as
- ACAT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Danville, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1781726
- Former names
- GJ Culture Group US, Inc. (until Sep 29, 2022)
Other Services-Educational Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.